TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06354517

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SENSE group
Description: Parents of babies in this group will be given SENSE program training. After the training, parents will care for their babies within the scope of the SENSE program. These babies will receive care from their parents with positive sensory exposures within the scope of the SENSE program from admission to the clinic until discharge. Data collection forms will be administered to babies and their parents.
Study: NCT04482582

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Cryoneurolysis
Description: Patients will be offered a minimally invasive solution known as cryoneurolysis. By directly applying a cold cryoneurolysis probe to the nerves the axon is destroyed, resulting in Wallerian degeneration of the distal nerve without distorting epineurial or perineurial tissue. Application of cryoneurolysis will help reduce the amount of narcotics the patient would need to take and instead provide them longer term pain control with minimal risk.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Patients will be provided regular standard of care at the Stanford Hospital with long-term follow-up provided at the Stanford Center for Reconstruction after Chest Wall Injury.
Study: NCT05303818

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 MG
Description: Patients in post-operative colonic cancer will receive rivaroxaban 10mg/daily for 28 days after surgery
Study: NCT06572124

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: universal adhesive without Acid resistant silane coupling agent
Description: After cavity preparations, enamel margins will be etched for 30 seconds then rinsed and dried, then the Universal adhesive without acid resistant silane coupling agent will be actively applied for 20 seconds then air thinned for 5 seconds then cured for 20 seconds.Then the composite restoration will be placed.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: universal adhesive with Acid resistant silane coupling agent
Description: After cavity preparations, enamel margins will be etched for 30 seconds then rinsed and dried, then the Universal adhesive which contains acid resistant silane coupling agent will be actively applied for 20 seconds then air thinned for 5 seconds then cured for 20 seconds.Then the composite restoration will be placed.
Study: NCT05531864

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous low serratus anterior plane block
Description: Low anterior serratus plane block, move the mid-axillary line 4 and 5 intercostal puncture points are moved down and the puncture is changed to 7 and 8 intercostal.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound-guided single serratus anterior plane block
Description: Ultrasound-guided single anterior saw plane block was performed, and a needle was injected between the 4th and 5th costals in the midaxillary line.
Study: NCT05136989

Intervention type: BEHAVIORAL
Intervention: Individual and collective semi-structured interviews
Description: Individual and collective semi-structured interviews will be performed with professionals to identify levers (practices, knowledge, tools, regulations) which, at the level of services and establishments, enable the development of a policy of less recourse to coercion

Intervention type: BEHAVIORAL
Intervention: Individual semi-structured interviews with ex-patients
Description: Individual semi-structured interviews will be performed with ex-patients in order to gather their experiences in the seven institutions concerned and to better understand the impact of their hospitalization in these institutions on their lives

Intervention type: BEHAVIORAL
Intervention: Observations out in the services
Description: Observations will be carried out in the services in order to measure the gap between rhetoric and practice, and to observe the effective implementation of lesser use practices
Study: NCT05461404

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical Emollient Therapy
Description: Application of high-linoleate (\>60% linoleic acid) SSO to the epidermis.
Study: NCT05503758

Intervention type: DEVICE
Intervention: Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia)
Description: The MyotoPRO device is a portable objective device for measuring the contractile (tone), and biomechanical (stiffness) properties of lumbar paravertebral muscles (LPVMs).

Intervention type: DEVICE
Intervention: Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia)
Description: The MyotoPRO device is a portable objective device for measuring the contractile (tone), and biomechanical (stiffness) properties of lumbar paravertebral muscles (LPVMs).

Intervention type: DEVICE
Intervention: Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia)
Description: The MyotoPRO device is a portable objective device for measuring the contractile (tone), and biomechanical (stiffness) properties of lumbar paravertebral muscles (LPVMs).

Intervention type: DEVICE
Intervention: Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia)
Description: The MyotoPRO device is a portable objective device for measuring the contractile (tone), and biomechanical (stiffness) properties of lumbar paravertebral muscles (LPVMs).
Study: NCT06050928

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral EP262
Description: Once daily
Study: NCT06008938

Intervention type: GENETIC
Intervention: HEMGENIX
Description: HEMGENIX is a gene therapy medicinal product that aims to deliver a factor IX (FIX) gene expression cassette to the liver of patients with hemophilia B.

Intervention type: BIOLOGICAL
Intervention: Factor IX (FIX)
Description: FIX prophylaxis therapy
Study: NCT06423521

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of Care (SOC)
Description: The SOC intervention constitutes the common clinical practice of care that is habitually performed after cardiac surgery to manage anticoagulation therapies.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote Patient Monitoring (RPM)
Description: The RPM intervention involves the use of a remote patient monitoring (RPM) system with a portable coagulometer for the clinical follow-up and self-management of International Normalized Ratio (INR) control in patients undergoing anticoagulant therapy post-cardiac surgery. Patients were provided with a Coagulometer-CoaguChek® (Roche Diagnostics, Switzerland) kit and test strips, along with written instructions for conducting measurements. They were also enrolled in a monitoring platform. Patients received regular text messages on their smartphones to report their INR values and symptoms related to anticoagulant therapy. The clinical team received notifications if patients\&amp;#39; reports fell outside therapeutic standards and then responded with medication adjustments via text message.
Study: NCT05836649

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Oculus Go headset without active intervention
Description: VR software with non-interactive content.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Oculus Go headset without active intervention
Description: VR software with non-interactive content.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Oculus Go headset with active intervention
Description: Participant will engage with the game display on the VR headset. Engagement time depends on the HPT limits test.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Oculus Go headset with active intervention
Description: Participant will engage with the game display on the VR headset. Engagement time depends on the HPT limits test.
Study: NCT06522373

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-0169
Description: Given by Vein (IV)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-0169
Description: Given by Vein (IV)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-0169
Description: Given by Vein (IV)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-0169
Description: Given by Vein (IV)
Study: NCT06465394

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Neck exercises in a cross over design that the participants will do both types of interventions with a washout period inbetween.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Neck exercises in a cross over design that the participants will do both types of interventions with a washout period inbetween.
Study: NCT06372158

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Stage 1
Description: Number 1-10 :General vitamin C powder group (Contains 1500 mg Ca); Number 11-20: liposomal encapsulation Ca powder group (Contains 1500 mg of Ca and lecithin and is coated)

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Stage 2
Description: Number 11-20 :General vitamin C powder group (Contains 1500 mg Ca); Number 1-10: liposomal encapsulation Ca powder group (Contains 1500 mg of Ca and lecithin and is coated)
Study: NCT05428215

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 17beta Estradiol
Description: Subjects will take individualized therapeutic dose of 17-beta-estradiol via sublingual and oral administration

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 17beta Estradiol
Description: Subjects will take individualized therapeutic dose of 17-beta-estradiol via sublingual and oral administration
Study: NCT05702983

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STSA-1002 subcutaneous injection
Description: Subjects will receive a single low dose on day 1 following protocol requirements.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STSA-1002 subcutaneous injection
Description: Subjects will receive a single high dose on day 1 following protocol requirements.
Study: NCT05812183

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Description: Gastric sleeve resection will be performed by experienced surgeons. Postoperative care will follow UCLA's postoperative care pathways for gastric sleeve resection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medical weight loss
Description: The medical weight loss intervention will follow UCLA's RFO standard protocol. Over a period of 12 months, patients in the medical weight loss group will follow a very low caloric diet (VLCD) at the UCLA RFO program. All study patients will be prescribed a VLCD, an exercise regimen and will participate in group classes on behavioral modification. The caloric intake consists of a commercially prepared meal replacement powder supplying 700-800 cal/day. Each formula packet provides 100kcal and 15g of high biological value protein, and the daily allowance of required minerals and vitamins. Some patients may recieve adjuvant drug therapy including Orlistat (Xenical, Alli), Phentermine-topiramate (Qsymia), Naltrexone-bupropion (Contrave), Liraglutide (Saxenda), Semaglutide (Wegovy), Tirzepatide (Zepbound) or Setmelanotide (Imcivree).
Study: NCT06040905

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Description: 300 mg/day (150mg/b.i.d)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Starch, dextrin
Study: NCT06420115

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: different needle size for prostate biopsy
Description: MRI Fusion Transperineal Prostate Biopsy

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: different needle size for prostate biopsy
Description: MRI Fusion Transperineal Prostate Biopsy
Study: NCT05954559

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elucirem (Gadopiclenol)
Description: Elucirem (Gadopiclenol) is a new macrocyclic gadolinium-based contrast agent (GBCA) with high relaxivity indicated for use in adults and children aged 2 years and older for contrast-enhanced magnetic resonance imaging.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elucirem (Gadopiclenol)
Description: Elucirem (Gadopiclenol) is a new macrocyclic gadolinium-based contrast agent (GBCA) with high relaxivity indicated for use in adults and children aged 2 years and older for contrast-enhanced magnetic resonance imaging.
Study: NCT05609188

Intervention type: OTHER
Group type: OTHER
Intervention: Guaranteed Income
Description: Monthly cash transfer of $500 per month for 12 months.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Guaranteed Income
Description: Monthly cash transfer of $500 per month for 12 months.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Peer learning circles
Description: Participants can opt-in to attend peer learning circles (also called My Money Hour), which are discussion groups of 10-12 participants about financial topics co-led by a peer (Black youth) with experience in financial programming and an adult financial coach. My Money Hour sessions will be offered on-line multiple times throughout every month of the project, with rotating themes, to ensure that the 50-minute sessions are available different days of the week and times of the day.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer learning circles
Description: Participants can opt-in to attend peer learning circles (also called My Money Hour), which are discussion groups of 10-12 participants about financial topics co-led by a peer (Black youth) with experience in financial programming and an adult financial coach. My Money Hour sessions will be offered on-line multiple times throughout every month of the project, with rotating themes, to ensure that the 50-minute sessions are available different days of the week and times of the day.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Financial coaching
Description: Participants can opt-in to receive financial coaching sessions with a trained financial mentor. Meetings will occur monthly and typically include six one hour sessions. The mentor will be responsive to individual needs, but will touch on the following priority areas: building credit (credit repair, improving credit scores, credit products); savings (emergency savings plans, savings habits and strategies, understanding savings accounts); money management (creating budgets, understanding income vs expense, assessing spending, making better financial decisions); financial products (credit building products, auto loans, credit cards); and long-term goals (home ownership, investments).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial coaching
Description: Participants can opt-in to receive financial coaching sessions with a trained financial mentor. Meetings will occur monthly and typically include six one hour sessions. The mentor will be responsive to individual needs, but will touch on the following priority areas: building credit (credit repair, improving credit scores, credit products); savings (emergency savings plans, savings habits and strategies, understanding savings accounts); money management (creating budgets, understanding income vs expense, assessing spending, making better financial decisions); financial products (credit building products, auto loans, credit cards); and long-term goals (home ownership, investments).
Study: NCT05332171

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pyhsiohterapy and rehabilitation
Description: Before starting the exercise program, 10 repetitive warm-up exercises will be given including the lower and upper extremities and distal joints. The exercises will be started with 5 repetitions in the first week. Depending on the patient's tolerance, the intensity of the exercise will be increased as 10 repetitions, 15 repetitions and 20 repetitions, and optional rest will be allowed between exercises. It is aimed that the patients reach 20 repetitions in the 6th week at the latest.
Study: NCT06012149

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Braining
Description: A 12 week program where participants are encouraged to participate in physical exercise at the psychiatric unit.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Structured advice on physical activity
Description: A 12 week program where participants are encouraged to engage in physical exercise
Study: NCT03730051

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gadoterate meglumine
Description: Participants randomized into this arm will receive gadoterate meglumine contrast for their scheduled breast MRI.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadobutrol
Description: Participants randomized into this arm will receive gadobutrol contrast for their scheduled breast MRI.
Study: NCT06112691

Intervention type: DEVICE
Intervention: taking fundus photos using non-mydriatic fundus camera - FundusScope Rodenstock
Description: using artificial intelligence to identify diabetic retinopathy in the early stages using fundus photography.

Intervention type: DEVICE
Intervention: taking fundus photos using non-mydriatic fundus camera - FundusScope Rodenstock
Description: using artificial intelligence to identify diabetic retinopathy in the early stages using fundus photography.
Study: NCT06098248

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: cCeLL - Ex vivo
Description: Neoplastic brain tissue biopsied from participant will be visualized, and images will be captured using cCeLL - Ex vivo.
Study: NCT04827420

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mi Quit Care
Description: Demonstrating the feasibility, effectiveness, and cost-effectiveness of electronically delivered smoking cessation interventions via patient portals in Federally Qualified Health Care (FQHC) settings has the potential for wide-spread dissemination and significant public health impact. on patient populations with demonstrated high rates of smoking.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mi Quit Care
Description: Demonstrating the feasibility, effectiveness, and cost-effectiveness of electronically delivered smoking cessation interventions via patient portals in Federally Qualified Health Care (FQHC) settings has the potential for wide-spread dissemination and significant public health impact. on patient populations with demonstrated high rates of smoking.
Study: NCT05867875

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unblinded ORI values
Description: ORI and SpO2 monitoring will be performed using Masimo Rad 7 and both values will be provided to investigator

Intervention type: OTHER
Group type: OTHER
Intervention: Blinded ORI values
Description: ORI and SpO2 monitoring will be performed using Masimo Rad 7 and only SpO2 values will be provided to investigator
Study: NCT06248203

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tealeaf-Mansik Swasta (Tealeaf) as adapted for Adolescents
Description: The investigators will test Tealeaf (Teachers Leading the Frontlines - Mansik Swastha \[Mental Health in Nepali\]) as adapted for adolescents. Tealeaf is a task-shifting intervention in which teachers deliver transdiagnostic mental health care. Created in Darjeeling, Tealeaf centers on training and supervising teachers to deliver education as mental health therapy (Ed-MH) to children (age 5-12). Ed-MH is the investigators' novel, task-shifting, therapy modality that minimizes the time teachers need to deliver care by fitting it into their work. In Ed-MH, teachers use evidence-based therapeutic techniques adapted for use in their existing interactions with students in need (e.g., while teaching) and streamlined for care for any diagnosis (transdiagnostic). Tealeaf-A's adaptation (inclusive of Ed-MH) is supported by a Doris Duke Charitable Foundation (DDCF), Fund to Retain Clinical Scientists (FRCS), Caregivers at Carolina COVID award.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Description: Enhanced Usual Care (EUC) is a less intensive version of the Tealeaf intervention. The EUC service package has been designed to be the most intensive form of care that could be envisioned as viable in the study setting in the foreseeable future without a significant increase in resource investment.
Study: NCT04677010

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cycle exercise
Description: 10 weeks of cycle exercise on a cycle ergometer with motor.
Study: NCT05144711

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Selective caries excavation
Description: Selective caries excavation leaving stained but leathery dentine towards the pulp

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non selective caries excavation
Description: Complete excavation of caries regardless of the risk of pulp exposure
Study: NCT05398978

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: e-Registration and mHealth
Description: Registration to the electronic database Counseling through voice calls for facility delivery Text messages to promote facility delivery
Study: NCT05832645

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Meditation with guided tea consumption
Description: Mindful consumption of tea along with an approximately 10-min guide

Intervention type: OTHER
Group type: OTHER
Intervention: Breathing meditation
Description: 10-min breathing meditation
Study: NCT06555172

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Action In Mindfulness (AIM)+
Description: AIM+ is a smartphone-based app that teaches mindfulness meditation to professionals working with legal-involved youth over a 30-day path. Each day of the path consists of a brief (approximately 5- to 10-minute) audio-guided meditation practice, with brief videos interspersed to illustrate key concepts and promote engagement. In addition to the 30 daily path files, users have access to a menu of to go audio-guided meditation practices that they can use as relevant to their workday (e.g., for professionals to listen to before attending a meeting). AIM+ also includes a menu of audio-guided meditation practices that officers can share with the youth on their caseloads (e.g., for youth to listen to before attending court).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Resource+
Description: Resource+ is a smartphone-based app that is matched to AIM+ for time and structure, but it includes information on community resources that professionals can provide to the youth with whom they work in place of the meditation content featured in AIM+.
Study: NCT06001177

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KAN-101
Description: Dose KAN-101 Intravenous (IV) Infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Intravenous (IV) Infusion
Study: NCT04924608

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selumetinib
Description: Selumetinib oral capsules (10 mg and 25 mg)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo oral capsules for Selumetinib masking (10 mg and 25 mg)